miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis.
暂无分享,去创建一个
James T. Elder | C. Gieger | M. Weichenthal | C. Akdis | A. Franke | R. Trembath | P. Peterson | L. Tsoi | K. Abram | K. Kingo | P. Reemann | J. Barker | U. Mrowietz | S. Weidinger | M. Boldin | E. Tkaczyk | H. Baurecht | E. Rodriguez | K. Kisand | E. Prans | A. Aab | A. Rebane | U. Haljasorg | J. Maslovskaja | B. Kaldvee | B. Rückert | M. Karelson | P. Wawrzyniak | Nathaniel Magilnick | H. Hermann | T. Runnel | E. Urgard | Liisi Šahmatova | Bret Kaldvee | Julia Maslovskaja | Alar Aab
[1] P. Nikamo,et al. MicroRNA‐146a suppresses IL‐17–mediated skin inflammation and is genetically associated with psoriasis , 2017, The Journal of allergy and clinical immunology.
[2] Norbert Meyer,et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases. , 2016, The Journal of allergy and clinical immunology.
[3] T. Maimets,et al. Pre-administration of PepFect6-microRNA-146a nanocomplexes inhibits inflammatory responses in keratinocytes and in a mouse model of irritant contact dermatitis. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[4] Dong Joo Kim,et al. Molecular Phenotyping Small (Asian) versus Large (Western) Plaque Psoriasis Shows Common Activation of IL-17 Pathway Genes, but Different Regulatory Gene Sets , 2015, The Journal of investigative dermatology.
[5] K. Abram,et al. MicroRNA-155 is Dysregulated in the Skin of Patients with Vitiligo and Inhibits Melanogenesis-associated Genes in Melanocytes and Keratinocytes. , 2016, Acta dermato-venereologica.
[6] M. Lebwohl,et al. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials , 2015, The Lancet.
[7] E. Izaurralde. Breakers and blockers—miRNAs at work , 2015, Science.
[8] A. Armstrong,et al. Psoriasis and risk of diabetes-associated microvascular and macrovascular complications. , 2015, Journal of the American Academy of Dermatology.
[9] W. Fu,et al. Meta-Analysis of MicroRNA-146a rs2910164 G>C Polymorphism Association with Autoimmune Diseases Susceptibility, an Update Based on 24 Studies , 2015, PloS one.
[10] Vinod Chandran,et al. Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci , 2015, Nature Communications.
[11] M. Hafner,et al. Laser capture microdissection followed by next‐generation sequencing identifies disease‐related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis , 2015, Experimental dermatology.
[12] James T. Elder,et al. Genome-wide Comparative Analysis of Atopic Dermatitis and Psoriasis Gives Insight into Opposing Genetic Mechanisms , 2015, American journal of human genetics.
[13] S. Kõks,et al. Melanocytes in the Skin – Comparative Whole Transcriptome Analysis of Main Skin Cell Types , 2014, PloS one.
[14] C. Akdis,et al. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. , 2014, The Journal of allergy and clinical immunology.
[15] Sen Guo,et al. A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study , 2014, Journal of cellular and molecular medicine.
[16] B. Elewski,et al. Secukinumab in plaque psoriasis--results of two phase 3 trials. , 2014, The New England journal of medicine.
[17] A. Pivarcsi,et al. MiR-146a negatively regulates TLR2-induced inflammatory responses in keratinocytes. , 2014, The Journal of investigative dermatology.
[18] T. Ridky,et al. Kindler syndrome in mice and men , 2014, Cancer biology & therapy.
[19] Michael R Green,et al. miR-146a promotes the initiation and progression of melanoma by activating Notch signaling , 2014, eLife.
[20] Shu-Chun Lin,et al. miR-146a Enhances the Oncogenicity of Oral Carcinoma by Concomitant Targeting of the IRAK1, TRAF6 and NUMB Genes , 2013, PloS one.
[21] C. Jung,et al. MicroRNA-146b promotes adipogenesis by suppressing the SIRT1-FOXO1 cascade , 2013, EMBO molecular medicine.
[22] F. Bazzoni,et al. Negative regulation of Toll-like receptor 4 signaling by IL-10–dependent microRNA-146b , 2013, Proceedings of the National Academy of Sciences.
[23] J. Krueger. Hiding under the skin: A welcome surprise in psoriasis , 2012, Nature Medicine.
[24] D. Salinger,et al. Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial. , 2012, The Journal of investigative dermatology.
[25] A. Krogh,et al. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer , 2012, Molecular Cancer.
[26] J. Ortonne,et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. , 2012, The New England journal of medicine.
[27] David Baltimore,et al. MicroRNAs, new effectors and regulators of NF‐κB , 2012, Immunological reviews.
[28] Matti Pirinen,et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity , 2012 .
[29] R. Kolde,et al. MicroRNA Expression Profiles of Human Blood Monocyte-derived Dendritic Cells and Macrophages Reveal miR-511 as Putative Positive Regulator of Toll-like Receptor 4* , 2011, The Journal of Biological Chemistry.
[30] Nan Shen,et al. A Functional Variant in MicroRNA-146a Promoter Modulates Its Expression and Confers Disease Risk for Systemic Lupus Erythematosus , 2011, PLoS genetics.
[31] J. Krueger,et al. Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts. , 2011, The Journal of allergy and clinical immunology.
[32] P. Linsley,et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice , 2011, The Journal of experimental medicine.
[33] J. Krueger,et al. Contrasting pathogenesis of atopic dermatitis and psoriasis--part I: clinical and pathologic concepts. , 2011, The Journal of allergy and clinical immunology.
[34] C. Akdis,et al. TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis. , 2011, The Journal of allergy and clinical immunology.
[35] David Baltimore,et al. Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses , 2010, Cell.
[36] S. Yuspa,et al. Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice , 2008, Nature Protocols.
[37] P. Janson,et al. MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis? , 2007, PloS one.
[38] U. Schlötzer-Schrehardt,et al. Kindlin-1 Is a Phosphoprotein Involved in Regulation of Polarity, Proliferation, and Motility of Epidermal Keratinocytes* , 2006, Journal of Biological Chemistry.
[39] D. Baltimore,et al. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.